New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Emergent BioSolutions Inc.
EBS
Shape
US Flag

NYSE

Unprofitable

Unprofitable

281M

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 May 2025

281M

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 May 2025

7.97USD

Shape-0.37 ( -4.44%)
sun-fogPre-market 5.35$arrow-left-down-0.18 (-3.30%)
Market Closed (as of Feb 19, 21:00 EDT)
favorite-chart

Relative Strenght

96
favorite-chart

Volume Buzz

182%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

47%

Quote Panel

Shape
Updated March 27, 2025
1W -9.62 % 1M -30.88 % 3M -44.11 % 1Y 104.35 %

Key Metrics

Shape
  • Market Cap

    280.92M


  • Shares Outstanding

    54.34M


  • Share in Float

    52.32M


  • Dividende

    0


  • Earning Date

    07 May 2025


  • Price Target

    5.17


  • Average Volume

    1.17M


  • Beta

    1.802


  • Range

    1.82-15.1


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.emergentbiosolutions.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

EBS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

Analyst rating

Last analyst upgrade/downgrade

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-3.17
vs 0.18

Q2.23

arrow
arrow

N/A

-1.06
vs -0.86

Q3.23

arrow
arrow

N/A

-1.44
vs -1.27

Q4.23

arrow
arrow

N/A

-0.77
vs -0.31

Q1.24

arrow
arrow

+119%

0.59
vs -3.17

Q2.24

arrow
arrow

N/A

-2.32
vs -1.06

Q3.24

arrow
arrow

+195%

1.37
vs -1.44

Q4.24

arrow
arrow

+106%

0.05
vs -0.77

Q1.25

arrow
arrow

-18%

0.49
vs 0.59

Q2.25

arrow
arrow

+102%

0.04
vs -2.32

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-46%

165.1M  vs 307.5M

Q2.23

arrow
arrow

+39%

337.9M  vs 242.7M

Q3.23

arrow
arrow

+13%

270.5M  vs 240M

Q4.23

arrow
arrow

-16%

276.6M  vs 330.7M

Q1.24

arrow
arrow

+82%

300.4M  vs 165.1M

Q2.24

arrow
arrow

-25%

254.7M  vs 337.9M

Q3.24

arrow
arrow

+9%

293.8M  vs 270.5M

Q4.24

arrow
arrow

-32%

189.3M  vs 276.6M

Q1.25

arrow
arrow

-29%

212.3M  vs 300.4M

Q2.25

arrow
arrow

-25%

191.9M  vs 254.7M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-15%

-0.15
vs -0.06

Q2.23

arrow
arrow

-27%

-0.27
vs -0.15

Q3.23

arrow
arrow

-38%

-0.38
vs -0.27

Q4.23

arrow
arrow

-8%

-0.08
vs -0.38

Q1.24

arrow
arrow

+1%

0.01
vs -0.08

Q2.24

arrow
arrow

-73%

-0.73
vs 0.01

Q3.24

arrow
arrow

+23%

0.23
vs -0.73

Q4.24

arrow
arrow

-6%

-0.06
vs 0.23

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

196

196
vs 202

-3%

Q2.23

arrow
arrow

190

190
vs 196

-3%

Q3.23

arrow
arrow

166

166
vs 190

-13%

Q4.23

arrow
arrow

139

139
vs 166

-16%

Q1.24

arrow
arrow

126

126
vs 139

-9%

Q2.24

arrow
arrow

142

142
vs 126

13%

Q3.24

arrow
arrow

150

150
vs 142

6%

Q4.24

arrow
arrow

165

165
vs 150

10%

Earnings Growth

Latest News